Browsing Category
Pharma Industry News
4763 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
AbbVie reports positive long-term results for atogepant in migraine prevention
AbbVie Inc. (NYSE: ABBV) has announced encouraging findings from an interim analysis of a 156-week extension study, assessing…
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9bn in strategic expansion
In a major development in the biotechnology industry, Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Alpine Immune Sciences, Inc.…
Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders
Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by…
Seaport Therapeutics rakes in $100m for neuropsychiatric medicine advancement
Seaport Therapeutics, a pioneering clinical-stage biopharmaceutical company, has successfully closed an oversubscribed Series A financing round, securing $100…
Ascentage Pharma showcases novel drug candidates at AACR 2024
Ascentage Pharma (6855.HK), a prominent global biopharmaceutical firm, recently unveiled the latest preclinical study results for its innovative…
Innovent Biologics showcases promising preclinical data at AACR 2024
In a significant development for cancer research, Innovent Biologics, Inc. (HKEX: 01801), a leading biopharmaceutical company renowned for…
Cynata Therapeutics wraps up patient enrollment for diabetic foot ulcers clinical trial
In a significant development for diabetic foot ulcer treatments, Cynata Therapeutics Limited (ASX: CYP), a leading clinical-stage biotechnology…
AstraZeneca’s Imfinzi demonstrates significant survival benefits in Phase 3 ADRIATIC trial
In a significant advancement for cancer treatment, AstraZeneca’s Imfinzi (durvalumab) has emerged as the first and only immunotherapy…
RTW Biotech Opportunities joins $160.5m Series C of Obsidian Therapeutics
RTW Biotech Opportunities Ltd, an investment company listed on the London Stock Exchange and specialized in the life…
Gland Pharma receives USFDA approval for first generic Eribulin Mesylate Injection
In a significant advancement for generic pharmaceuticals, Gland Pharma Limited, a company specializing in generic injectable-focused pharmaceutical products,…